The hottest new programming language is English. Andrej Karpathy, OpenAI co-founder and former Tesla AI director, said this ...
NPR's Scott Detrow speaks to playwright Kenn Adams about his formula for creating or analyzing stories called the Story Spine ...
No AI tool could have written The Declaration of Independence because it required human intuition, creativity, and ...
Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
The Israeli military has used a targeting system powered by artificial intelligence to launch what it says are attacks on Hezbollah in Lebanon. The system fuses data from various sources, including ...
In yet another software supply chain attack, threat actors have managed to compromise the popular Python package Lightning to push two malicious versions to conduct credential theft. As of writing, ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...
We may receive a commission on purchases made from links. ByteDance released Seedance 2.0 less than a week ago and enraged artists everywhere with a viral clip AI-generated clip of Tom Cruise and Brad ...
Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...